Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access

This publication has 10 references indexed in Scilit:

• Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
  MMWR. Morbidity and Mortality Weekly Report, 2019
• Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
  JAMA Network Open, 2019
• Community Pharmacist Utilization of Legislation That Allows Impact on the Opioid Crisis in the State of Minnesota: A Mixed-Methods Approach
  Journal of Pharmacy Practice, 2019
• Naloxone Deserts in NJ Cities: Sociodemographic Factors Which May Impact Retail Pharmacy Naloxone Availability
  Journal of Medical Toxicology, 2019
• Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
  MMWR. Morbidity and Mortality Weekly Report, 2018
• Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation
  JAMA, 2018
• Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid
  Drug and Alcohol Dependence, 2018
• Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina
  Journal of the American Pharmacists Association, 2018
• State legal innovations to encourage naloxone dispensing
  Journal of the American Pharmacists Association, 2017
• Is the Prescription Opioid Epidemic a White Problem?
  American Journal of Public Health, 2016